Prokidney Corp (PROK)

$2.09 -0.10 (-4.57%)
Market Cap 658.83M
Revenue (ttm) 80,000.00
Net Income (ttm) -61.19M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -76,487.50%
Debt to Equity Ratio 0.00
Volume 399,200
Avg Vol 1,061,092
Day's Range N/A - N/A
Shares Out 300.83M
Stochastic %K 68%
Beta 1.78
Analysts Sell
Price Target $5.50

Company Profile

ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2...

Industry: Biotechnology
Sector: Healthcare
Phone: 336 999 7028
Address:
2000 Frontis Plaza Blvd., Suite 250, Winston-Salem, United States
wavridr
wavridr Feb. 20 at 9:06 PM
$PROK someone waited til close to dump 20k shares way below closing price. Makes sense 😂😂😂
0 · Reply
SmartWentCrazy
SmartWentCrazy Feb. 19 at 7:25 PM
$PROK
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 17 at 10:09 PM
$PROK Current Stock Price: $2.02 Contracts to trade: $2.0 PROK Feb 20 2026 Call Entry: $0.09 Exit: $0.17 ROI: 88% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JohnnySticks64
JohnnySticks64 Feb. 17 at 8:04 PM
$PROK On Thursday, February 12 - a new above 5% shareholder appeared – Morgan Stanley filed a 13G – they now hold 6% of the class A shares as of December 31, 2025. The SEC filing is also available on the PROK website under Investors —> SEC filings.
1 · Reply
Biohacker
Biohacker Feb. 11 at 4:44 PM
$PROK 💩
0 · Reply
SmartWentCrazy
SmartWentCrazy Feb. 10 at 7:51 PM
$PROK
0 · Reply
wavridr
wavridr Feb. 6 at 5:54 PM
$PROK today proves this is the biggest POS 💩💩💩 it's gonna be red by EOD 😂😂
0 · Reply
wavridr
wavridr Feb. 6 at 3:41 PM
$PROK so far behind the rest of the market 😂😂
0 · Reply
Biohacker
Biohacker Feb. 5 at 9:02 PM
$PROK 💩
0 · Reply
wavridr
wavridr Feb. 5 at 6:36 PM
$PROK I wonder if anyone still thinks this POS isn't going to $1😂
0 · Reply
Latest News on PROK
ProKidney Stock: Differentiated CKD Approach Positions Rilparencel Favorably

Jan 31, 2026, 4:40 AM EST - 21 days ago

ProKidney Stock: Differentiated CKD Approach Positions Rilparencel Favorably

ProKidney Corp. (PROK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 14, 2026, 1:36 PM EST - 5 weeks ago

ProKidney Corp. (PROK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference

Jan 6, 2026, 7:30 AM EST - 6 weeks ago

ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference

ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

Nov 10, 2025, 4:15 PM EST - 3 months ago

ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025

Nov 6, 2025, 11:00 AM EST - 3 months ago

ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025

ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference

Oct 29, 2025, 7:30 AM EDT - 4 months ago

ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference

ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2025

Oct 20, 2025, 7:30 AM EDT - 4 months ago

ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2025

ProKidney: Slow-Burning 'Buy' Opportunity Based On 2027 Approval Of Kidney Disease Therapy

Sep 19, 2025, 10:52 AM EDT - 5 months ago

ProKidney: Slow-Burning 'Buy' Opportunity Based On 2027 Approval Of Kidney Disease Therapy

ProKidney Corp. (PROK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 8, 2025, 10:14 AM EDT - 5 months ago

ProKidney Corp. (PROK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

ProKidney Corp. (PROK) Presents At Citi's Biopharma Back To School Conference Transcript

Sep 3, 2025, 2:08 PM EDT - 6 months ago

ProKidney Corp. (PROK) Presents At Citi's Biopharma Back To School Conference Transcript

ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference

Aug 27, 2025, 7:30 AM EDT - 6 months ago

ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference

ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

Aug 12, 2025, 4:01 PM EDT - 6 months ago

ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel

Jul 15, 2025, 7:30 AM EDT - 7 months ago

ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel

Trump's latest tariff threats and the impact on markets, ProKidney stock jumps over 500%

Jul 9, 2025, 11:22 AM EDT - 8 months ago

Trump's latest tariff threats and the impact on markets, ProKidney stock jumps over 500%

ProKidney: What's Happening With PROK Stock?

Jul 9, 2025, 8:45 AM EDT - 8 months ago

ProKidney: What's Happening With PROK Stock?

ProKidney to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference

Jul 9, 2025, 7:30 AM EDT - 8 months ago

ProKidney to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference

ProKidney's stock rockets on ‘intriguing' news, but analyst doesn't recommend buying

Jul 8, 2025, 5:09 PM EDT - 8 months ago

ProKidney's stock rockets on ‘intriguing' news, but analyst doesn't recommend buying

Gold Falls 1%; ProKidney Shares Spike Higher

Jul 8, 2025, 1:25 PM EDT - 8 months ago

Gold Falls 1%; ProKidney Shares Spike Higher

Why Is Penny Stock ProKidney Trading Higher On Tuesday?

Jul 8, 2025, 9:05 AM EDT - 8 months ago

Why Is Penny Stock ProKidney Trading Higher On Tuesday?

ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes

Jul 8, 2025, 7:00 AM EDT - 8 months ago

ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes

ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware

Jul 1, 2025, 12:43 PM EDT - 8 months ago

ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware

ProKidney Reports First Quarter 2025 Financial Results and Business Highlights

May 12, 2025, 4:15 PM EDT - 10 months ago

ProKidney Reports First Quarter 2025 Financial Results and Business Highlights

ProKidney Reports Full Year 2024 Financial Results and Business Highlights

Mar 17, 2025, 7:30 AM EDT - 1 year ago

ProKidney Reports Full Year 2024 Financial Results and Business Highlights

Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm

Jan 31, 2025, 11:08 AM EST - 1 year ago

Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm

2025 Will Be A Major Year For ProKidney's Rilparencel In CKD Treatment

Jan 31, 2025, 6:10 AM EST - 1 year ago

2025 Will Be A Major Year For ProKidney's Rilparencel In CKD Treatment

ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference

Nov 26, 2024, 7:30 AM EST - 1 year ago

ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference

ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting

Nov 12, 2024, 7:30 AM EST - 1 year ago

ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting

ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference

Nov 5, 2024, 7:30 AM EST - 1 year ago

ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference

ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2024

Oct 14, 2024, 7:30 AM EDT - 1 year ago

ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2024

ProKidney to Participate in the UBS Virtual Organ Restoration Day

Oct 9, 2024, 7:30 AM EDT - 1 year ago

ProKidney to Participate in the UBS Virtual Organ Restoration Day

ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel's Registrational Path to Potential Approval in the U.S.

Sep 3, 2024, 7:30 AM EDT - 1 year ago

ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel's Registrational Path to Potential Approval in the U.S.

ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 27, 2024, 7:30 AM EDT - 1 year ago

ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

ProKidney Reports Business Updates and Second Quarter 2024 Financial Results

Aug 9, 2024, 7:00 AM EDT - 1 year ago

ProKidney Reports Business Updates and Second Quarter 2024 Financial Results

ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

Jun 11, 2024, 9:35 PM EDT - 1 year ago

ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

Jun 10, 2024, 4:15 PM EDT - 1 year ago

ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates

Jun 10, 2024, 6:30 AM EDT - 1 year ago

ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates

ProKidney to Participate in the Jefferies Global Healthcare Conference

May 29, 2024, 7:00 AM EDT - 1 year ago

ProKidney to Participate in the Jefferies Global Healthcare Conference

ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024

May 21, 2024, 7:00 AM EDT - 1 year ago

ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024

ProKidney Reports Business Updates and First Quarter 2024 Financial Results

May 10, 2024, 7:00 AM EDT - 1 year ago

ProKidney Reports Business Updates and First Quarter 2024 Financial Results

ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations

Mar 25, 2024, 6:05 AM EDT - 2 years ago

ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations

ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights

Mar 21, 2024, 7:49 PM EDT - 2 years ago

ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights

ProKidney to Participate in Jefferies Biotech on the Bay Summit

Feb 29, 2024, 4:05 PM EST - 2 years ago

ProKidney to Participate in Jefferies Biotech on the Bay Summit

ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer

Nov 30, 2023, 6:05 AM EST - 2 years ago

ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer

ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference

Nov 21, 2023, 6:05 AM EST - 2 years ago

ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference

ProKidney Corp. (PROK) Q3 2023 Earnings Call Transcript

Nov 16, 2023, 4:40 PM EST - 2 years ago

ProKidney Corp. (PROK) Q3 2023 Earnings Call Transcript

ProKidney Reports Third Quarter Financial Results

Nov 14, 2023, 6:05 AM EST - 2 years ago

ProKidney Reports Third Quarter Financial Results

ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates

Nov 13, 2023, 5:02 PM EST - 2 years ago

ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates

ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2023

Oct 30, 2023, 4:12 PM EDT - 2 years ago

ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2023

ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference

Sep 5, 2023, 6:05 AM EDT - 2 years ago

ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference

ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights

Aug 10, 2023, 4:10 PM EDT - 2 years ago

ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights

wavridr
wavridr Feb. 20 at 9:06 PM
$PROK someone waited til close to dump 20k shares way below closing price. Makes sense 😂😂😂
0 · Reply
SmartWentCrazy
SmartWentCrazy Feb. 19 at 7:25 PM
$PROK
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 17 at 10:09 PM
$PROK Current Stock Price: $2.02 Contracts to trade: $2.0 PROK Feb 20 2026 Call Entry: $0.09 Exit: $0.17 ROI: 88% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JohnnySticks64
JohnnySticks64 Feb. 17 at 8:04 PM
$PROK On Thursday, February 12 - a new above 5% shareholder appeared – Morgan Stanley filed a 13G – they now hold 6% of the class A shares as of December 31, 2025. The SEC filing is also available on the PROK website under Investors —> SEC filings.
1 · Reply
Biohacker
Biohacker Feb. 11 at 4:44 PM
$PROK 💩
0 · Reply
SmartWentCrazy
SmartWentCrazy Feb. 10 at 7:51 PM
$PROK
0 · Reply
wavridr
wavridr Feb. 6 at 5:54 PM
$PROK today proves this is the biggest POS 💩💩💩 it's gonna be red by EOD 😂😂
0 · Reply
wavridr
wavridr Feb. 6 at 3:41 PM
$PROK so far behind the rest of the market 😂😂
0 · Reply
Biohacker
Biohacker Feb. 5 at 9:02 PM
$PROK 💩
0 · Reply
wavridr
wavridr Feb. 5 at 6:36 PM
$PROK I wonder if anyone still thinks this POS isn't going to $1😂
0 · Reply
wavridr
wavridr Feb. 5 at 3:43 PM
$PROK how the fuk is this green 🤦
0 · Reply
SmartWentCrazy
SmartWentCrazy Feb. 4 at 7:40 PM
$PROK
0 · Reply
wavridr
wavridr Feb. 4 at 4:49 PM
$PROK beautiful 90k share dump 💩💩💩
0 · Reply
EvergreenProfit
EvergreenProfit Feb. 4 at 3:57 PM
$PROK is a biotech company (ProKidney) developing a cell therapy for chronic kidney disease; it is a clinical-stage company with a novel but unproven approach.
1 · Reply
wavridr
wavridr Feb. 4 at 3:34 PM
$PROK just need to hit 1.87 today 💩🔨🔨🔨
0 · Reply
Biohacker
Biohacker Feb. 4 at 3:32 PM
$PROK 💩
0 · Reply
SmartWentCrazy
SmartWentCrazy Feb. 3 at 9:17 PM
$PROK
0 · Reply
wavridr
wavridr Feb. 3 at 7:35 PM
$PROK annoying POS 😂
0 · Reply
wavridr
wavridr Feb. 3 at 3:17 PM
$PROK this will never see 2 again 😂💩
0 · Reply
wavridr
wavridr Feb. 3 at 2:50 PM
$PROK short all in! 🔨🔨🔨
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 2 at 7:43 PM
$PROK RSI: 35.83, MACD: -0.0698 Vol: 0.11, MA20: 2.21, MA50: 2.26 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
wavridr
wavridr Feb. 2 at 5:22 PM
$PROK 160k shares at 2.09 😂😂 dumping that into market will take it below 2 again
0 · Reply